Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School , Boston, MA, USA.
Semin Ophthalmol. 2020 Aug 17;35(5-6):261-275. doi: 10.1080/08820538.2020.1810711. Epub 2020 Sep 16.
Cyclodestruction aims to reduce aqueous humor production through the coagulation or destruction of the ciliary body and has been an important treatment choice for glaucoma since the 1930s. The purpose of the current review is to highlight the evidence regarding the safety and efficacy of various cyclodestructive modalities, emphasizing peer-reviewed articles from the last 20 years and the most common variants of these procedures. The review focuses primarily on the two most common variants of transscleral cyclophotocoagulation (TS-CPC), continuous-wave diode cyclophotocoagulation (CW-TSCPC) and MicroPulse diode cyclophotocoagulation (MP-TSCPC) as well as endoscopic cyclophotocoagulation (ECP) and high-intensity focused ultrasound cyclodestruction (HIFU). We believe that the role of cyclodestruction in glaucoma treatment will only continue to expand given the advances in the field, particular with regards to targeted ciliary body destruction and improvement in the safety profile.
睫状体光凝术旨在通过睫状体的凝固或破坏来减少房水的产生，自 20 世纪 30 年代以来，一直是治疗青光眼的重要选择。本综述的目的是强调各种睫状体破坏性方法的安全性和有效性的证据，重点介绍过去 20 年的同行评议文章以及这些程序的最常见变体。本综述主要关注两种最常见的经巩膜睫状体光凝术（TS-CPC）变体，连续波二极管睫状体光凝术（CW-TSCPC）和微脉冲二极管睫状体光凝术（MP-TSCPC）以及内窥镜睫状体光凝术（ECP）和高强度聚焦超声睫状体光凝术（HIFU）。我们认为，鉴于该领域的进展，特别是在靶向睫状体破坏和提高安全性方面的进展，睫状体光凝术在青光眼治疗中的作用只会继续扩大。
